Clinical Trials Browser

Phase 2 × INDUSTRY × epoetin beta × Clear all

NCT02761642 2018-08-24

A Study to Evaluate Efficacy and Safety of Epoetin Beta (NeoRecormon®) in Anemic Participants With Breast Cancer Undergoing Chemotherapy

Phase 2 Completed

200 enrolled 13 charts

Classical hematology

Anemia